Evaluation of the Phytochemical, Antioxidant, Enzyme Inhibition, and Wound Healing Potential of Calotropis gigantea (L.) Dryand: A Source of a Bioactive Medicinal Product

Frontiers in Pharmacology
2021.0

Abstract

Traditionally, plants of the genus Calotropis have been used to cure various common diseases. The present research work explores the chemical and biological characterization of one of the most common species of this genus, i.e., Calotropis gigantea (L.) Dryand (syn. Calotropis gigantea (L.) Dryand.), having multiple folklore applications. The ethanolic extract of leaves of Calotropis gigantea (L.) Dryand was analyzed for the phytochemical composition by determining the total bioactive (total phenolic and total flavonoid) contents and UHPLC-MS secondary metabolites analysis. For phytopharmacological evaluation, in vitro antioxidant (including DPPH, ABTS, FRAP, CUPRAC, phosphomolybdenum, and metal chelation antioxidant assays) activities, enzyme inhibition potential (against AChE, BChE, alpha-amylase, and tyrosinase enzymes), and in vivo wound healing potential were determined. The tested extract has been shown to contain considerable flavonoid (46.75 mg RE/g extract) and phenolic (33.71 mg GAE/g extract) contents. The plant extract presented considerable antioxidant potential, being the most active for CUPRAC assays. Secondary metabolite UHPLC-MS characterization, in both the positive and negative ionization modes, indicated the tentative presence of 17 different phytocompounds, mostly derivatives of sesquiterpene, alkaloids, and flavonoids. Similarly, the tested extract exhibited considerable inhibitory effects on tyrosinase (81.72 mg KAE/g extract), whereas it showed weak inhibition ability against other tested enzymes. Moreover, in the case of in vivo wound healing assays, significant improvement in wound healing was observed in both the tested models at the doses of 0.5 percent w/w (p < 0.001) and 2.0 percent w/w (p < 0.01) on the 16(th) day. The outcomes of the present research work suggested that C. gigantea (L.) Dryand plant extract could be appraised as a potential origin of bioactive molecules having multifunctional medicinal uses. CI - Copyright (c) 2021 Alafnan, Sridharagatta, Saleem, Khurshid, Alamri, Ansari, Zainal Abidin, Ansari, Alamri, Ahemad and Anwar.

Knowledge Graph

Similar Paper

Evaluation of the Phytochemical, Antioxidant, Enzyme Inhibition, and Wound Healing Potential of Calotropis gigantea (L.) Dryand: A Source of a Bioactive Medicinal Product
Frontiers in Pharmacology 2021.0
Phytochemical and cytotoxic studies on the leaves of Calotropis gigantea
Bioorganic &amp; Medicinal Chemistry Letters 2017.0
A new β -carboline-type alkaloid from the flowers of Calotropis gigantea (L.) W.T.Aiton
Natural Product Research 2024.0
Bio-chemical characterization and in silico computational experimental properties of Trianthema triquetra Rottler &amp; Willd.: A desert medicinal plant for industrial products
Industrial Crops and Products 2022.0
New insights into the phytochemical composition, enzyme inhibition and antioxidant properties of desert cotton (Aerva javanica (Bum.f) Shult. -Amaranthaceae)
Natural Product Research 2021.0
Antioxidant and Cytotoxic Flavonols from Calotropis procera
Zeitschrift für Naturforschung C 2011.0
Calosides A–F, Cardenolides from <i>Calotropis gigantea</i> and Their Cytotoxic Activity
Journal of Natural Products 2020.0
Indonesian Medicinal Plants. V. Chemical Structures of Calotroposides C, D, E, F, and G, Five Additional New Oxypregnane-Oligoglycosides from the Root of Calotropis gigantea (Asclepiadaceae).
Chemical and Pharmaceutical Bulletin 1992.0
Secondary metabolites from Calotropis procera (Aiton)
Phytochemistry Letters 2010.0
19-Nor- and 18,20-Epoxy-cardenolides from the Leaves of <i>Calotropis gigantea</i>
Journal of Natural Products 2006.0